SRTS News and Press, Sensus Healthcare Inc.

2024-05-17 09:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-11 11:32:09 ET Sensus Healthcare, Inc. (SRTS) Q1 2024 Earnings Conference Call May 09, 2024, 04:30 PM ET Company Participants Kim Golodetz - LHA, IR Joe Sardano - Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - CFO ...

A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 98.7% to $8.88 on volume of 168,692,127 shares AEye Inc. (LIDR) rose 115.0% to $2.58 on volume of 156,236,079 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 17.3% to $0.7609 on volume of 123,678,040 s...

2024-05-10 12:57:54 ET Gainers: Novavax NVAX +106% . AEye LIDR +67% . ITeos Therapeutics ITOS +48% . Sensus Healthcare SRTS +35% . Inseego Corp INSG +32% . Sweetgreen SG +33% . Organogenesis Holdings ORGO +33% . Caredx CDNA +32...

2024-05-09 16:15:05 ET More on Sensus Healthcare Sensus Healthcare Q1 2024 Earnings Preview Sensus Healthcare announces sale of first SRT-100 Vision System to Asia Seeking Alpha’s Quant Rating on Sensus Healthcare Historical earnings data for Sensus He...

Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter; A djusted EBITDA (a non-GAAP measure) of $3.0 million, compared with negative $2.7 million in the prior-year quarter Launched the “Fair Deal Agreement” recurring revenue program to pro...

First veterinary commercial sale of the SRT-100 outside the U.S. BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for onco...

2024-05-06 09:25:16 ET More on Sensus Healthcare Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript Sensus Healthcare announces U.S. patent for SRT-100 Vision System Sensus Healthcare Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating o...

Reminder: First Quarter 2024 Financial Results Reporting and Conference Call on May 9, 2024 BOCA RATON, Fla, May 06, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological...

BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, reminds investors that management will hold a conference call on...